Investigation of the effect of quercetin in an experimental oxygen-induced retinopathy model
DOI:
https://doi.org/10.30714/j-ebr.2021267976Keywords:
Oxygen-induced retinopathy, neovascularization, bevacizumab, quercetin, VEGF, TNF-α, ratsAbstract
Aim: Investigation of the effect of intraperitoneal (IP) quercetin and bevacizumab on oxygen-induced retinopathy (OIR) model in rats.
Methods: In the study, 28 newborn rats were used. The OIR model was performed with the 50/10% oxygen technique. The study consisted of four groups as a control group (Group I) and OIR groups (Group II, III, and IV). IP injection applied to all groups on the postnatal day (PND) 14. Groups I and II were performed 0.9% NaCl, Group III was performed IP bevacizumab, and Group IV was performed IP quercetin. All animals were sacrificed on PND 18.
Results: Based on the data obtained from immunohistochemical and histopathological examinations, the number of vascular endothelial cell (VEC), vascular endothelial growth factor (VEGF), and tumor necrosis factor-α (TNF-α) levels were significantly reduced in Group III and IV compared to Group II. VECs levels were 0±0, 32.69±5.77, 2.92±0.63, and 3.64±0.36 in Group I, Group II, Group III, and Group IV, respectively (p<0.001). Likewise, VEGF values were 0.15±0.01, 7.57±1.80, 2.45±0.45, and 2.46±0.49, respectively (p<0.001). As well as TNF-α values were 0.06±0.01, 8.22±2.24, 2.32±0.32, and 2.29±0.26 in Group I, Group II, Group III, and Group IV, respectively (p<0.001). There was no significant difference between Group III and Group IV in terms of VEC, VEGF and TNF-α values (range of p values was 0.96-1.00).
Conclusion: The results of the present study showed that quercetin administration significantly reduced the VEC number and suppressed VEGF and TNF-α. Quercetin's anti-inflammatory and anti-angiogenesis effect was found to be similar to bevacizumab.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Abdulgani Kaymaz, Fatih Ulas, Sevilay Erimsah, Cansu Kara Oztabag

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright Holder-Author (s)